AtriCure, Inc. (ATRC) income statement
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.45+0.43 (+0.78%)
Close on Nov 18, 2026Market cap $2.82BP/E 264.0Yield –
AtriCure, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 76.3%
- Operating margin
- 2.3%
- Net margin
- 1.9%
- Return on equity, FY2025
- -2.4%
Financial strength
- Current ratio
- 4.22
- Debt to equity
- 0.12
- Debt to assets
- 9.0%
- Cash to current liabilities
- 204.8%
Valuation
- P/E ratio
- 264.0
- Price to sales
- 4.95
- Price to book
- 5.46
- Dividend yield
- –
See a number that looks wrong?